Skip to content

UTMD - UTAH MEDICAL PRODUCTS INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchU

Utah Medical Products Inc

UTMD · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

U

UTMDUtah Medical Products Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $75.75
52-wk low: $52.87
Prev close: $69.90
Mkt cap: $229.6M
P/E: 21.9x
Fwd P/E: 13.0x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$35.3M

JS
Jim Simons
Q2 2026 13F
$12.1M
position
LA
LSV Asset
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Reasonably priced and profitable.

Net margin: 29.0%
P/E: 21.85
Forward P/E: 13.04
Market cap: $230M

Valuation

P/S6.36
P/B1.87
Dividend yield1.7%

Quality

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: UTMD
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Market cap: $229.62M
Beta: 0.36

Analysts

What do analysts expect?

No data yet

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

Beta

0.36

Div yield

1.72%

P/S

6.4x

P/B

1.9x

Profit margin

+29.0%

Op margin

+36.9%

ROE

+8.8%

$1.2M

position

AQ

AQR

Q2 2026 13F

$1.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for UTMD

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

Reports Oct 22, 2026, in 62 days

Operating margin36.9%

ROE8.8%

ROA6.1%

Growth

Beta0.36